₹ 0.5 Cr
Volume Transacted
()
57.1 K
Stocks Traded
()
Last Updated on: Nov 08, 2024
Balaxi Pharmaceuticals Ltd
NSE: BALAXI
EPS
₹ 5.98
Last updated on: Nov 07, 2024
Open Demat Account
Enter your mobile no. to continue
+91
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
Historical Earning per Share of Balaxi Pharmaceuticals Ltd
EPS, or Earnings Per Share, is a financial metric that represents the portion of a company's profit allocated to each outstanding share of common stock. It indicates a company's profitability and is calculated by dividing net income by the number of outstanding shares.
No data available
* All values are in ₹
The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.
1M
1Y
3Y
5Y
Date | Price (₹) | Day Open (₹) | Day High (₹) | Day Low (₹) |
---|
07 Nov 2024 | 86.66 | 89 | 89 | 85.6 |
06 Nov 2024 | 86.92 | 91 | 91.94 | 86.12 |
05 Nov 2024 | 89.97 | 88 | 90 | 88 |
04 Nov 2024 | 88.32 | 92 | 92 | 87.54 |
01 Nov 2024 | 90.99 | 89.5 | 92.7 | 89.5 |
31 Oct 2024 | 89.95 | 92.81 | 92.81 | 88.34 |
30 Oct 2024 | 89.98 | 91 | 91 | 88.11 |
29 Oct 2024 | 89.83 | 89.25 | 90 | 88.12 |
28 Oct 2024 | 89.24 | 88.61 | 90 | 86.87 |
25 Oct 2024 | 87.96 | 92.5 | 92.5 | 87.01 |
Date | Price (₹) |
---|---|
07 Nov 2024 | 86.66 |
06 Nov 2024 | 86.92 |
05 Nov 2024 | 89.97 |
04 Nov 2024 | 88.32 |
01 Nov 2024 | 90.99 |
31 Oct 2024 | 89.95 |
30 Oct 2024 | 89.98 |
29 Oct 2024 | 89.83 |
28 Oct 2024 | 89.24 |
25 Oct 2024 | 87.96 |
Strength
4
S
Weakness
1
W
Opportunity
0
O
Threats
1
T
Revenue
Profitability
Affordability
Liquidity
Dividend
Market Value
₹ 478
Asset Value
₹ 210
1.3 X
Value addition
* All values are in Rupees
Company Name | EPS | Market Cap (INR Cr.) |
---|---|---|
Balaxi Pharmaceuticals Ltd | 5 | 478 |
Sun Pharmaceuticals Industries Ltd | 46 | 4,29,841 |
Divis Laboratories Ltd | 63 | 1,58,179 |
Cipla Ltd | 57 | 1,27,063 |
Mankind Pharma Ltd | 52 | 1,09,234 |
Dr Reddys Laboratories Ltd | 63 | 1,07,398 |
Historical Market Cap of Balaxi Pharmaceuticals Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
No data available
* All values are in ₹ crore
Historical Revenue of Balaxi Pharmaceuticals Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
No data available
* All values are in ₹ crore
Historical EBITDA of Balaxi Pharmaceuticals Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
No data available
* All values are in ₹ crore
Historical Net Profit of Balaxi Pharmaceuticals Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
No data available
* All values are in ₹ crore
No data available
Balaxi Pharmaceuticals announces board meeting date
Balaxi Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 5 N...
30 Oct 202416:58
Balaxi Pharmaceuticals to conduct AGM
Balaxi Pharmaceuticals announced that the 81st Annual General Meeting(AGM) of the company ...
01 Aug 202412:52
Balaxi Pharmaceuticals to convene board meeting
Balaxi Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 2 A...
26 Jul 202410:45
Balaxi Pharma soars after expanding market presence in Angola & Latin America
In a regulatory filing made during market hours today, Balaxi Pharma stated that it has ha...
25 Jun 202412:14
Balaxi Pharmaceuticals to conduct board meeting
Balaxi Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 29 ...
24 May 202418:51
Balaxi Pharma edges higher after board approves stock split proposal
Accordingly, one equity share of the company, having face value of Rs 10 each, would be su...
28 Feb 202413:39
FAQs for EPS of Balaxi Pharmaceuticals Ltd
What is the EPS of Balaxi Pharmaceuticals Ltd stock?
How is Balaxi Pharmaceuticals Ltd EPS calculated?
How often does Balaxi Pharmaceuticals Ltd report its EPS?
What factors can influence Balaxi Pharmaceuticals Ltd EPS?
Can Balaxi Pharmaceuticals Ltd EPS growth indicate future performance?
Unlimited trading at just
Rs. 199*